Publications

5808 Results

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

Authors
A Herskovic;K Martz;M Al-Sarraf;L Leichman;J Brindle;V Vaitkevicius;J Cooper;R Byhardt;L Davis;B Emami
Journal / Conference
NEJM 326:1593-1598
Year
1992
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8598

False positive flow cytometric platelet glycoprotein IIb/IIIa expression in myeloid leukemias secondary to platelet adherence to blasts.

Authors
S Betz;K Foucar;DR Head;IM Chen;CL Willman
Journal / Conference
Blood 79:2399-2403
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Activation of EVI-1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.

Authors
K Morishita;E Paraganas;CL Willman;MH Whittaker;H Drabkin;J Oval;R Taetle;MB Valentine;JN Ihle
Journal / Conference
Proc Natl Acad Sci 89:3937-3941
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750

A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: A Southwest Oncology Group trial.

Authors
GR Weiss;PY Liu;J O'Sullivan;DS Alberts;TD Brown;JR Neefe;LF Hutchins
Journal / Conference
Gyn Onc 45:303-306
Year
1992
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8640

Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: Preliminary analysis of an Intergroup study (INT-0076).

Authors
LG Dressler;L Eudey ;R Gray;DC Tormey;WL McGuire;KW Gilchrist;CK Osborne;EG Mansour;MD Abeloff
Journal / Conference
JNCI Monographs 11:167-172
Year
1992
Research Committee(s)
Breast
Study Number(s)
SWOG-8696 (INT-0076) (EST-7186)

HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by presence in in situ carcinoma.

Authors
DC Allred;AK Tandon;R Molina;DC Tormey;CK Osborne;KW Gilchrist;EG Monsour;M Abeloff;L Eudey;WL McGuire
Journal / Conference
JCO 10:599-605
Year
1992
Research Committee(s)
Breast
Study Number(s)
SWOG-8696 (INT-0076) (EST-7186)

Phase II trial of didemnin-B in advanced epithelial ovarian cancer. A Southwest Oncology Group study.

Authors
JM Cain;PY Liu;DS Alberts;HH Gallion;L Laufman;J O'Sullivan;G Weiss;G Mills
Journal / Conference
IND 10:23-24
Year
1992
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8717

Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: A Southwest Oncology Group study.

Authors
HH Gallion;PY Liu;DS Alberts;RV O'Toole;J O'Sullivan;G Mills;HO Smith;HE Hynes
Journal / Conference
Gyn Onc 46:230-232
Year
1992
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8717

High incidence of coagulopathy in phase II studies of recombinant tumor necrosis factor (rTNF) in advanced pancreatic and gastric cancers.

Authors
FM Muggia;TD Brown;PJ Goodman;EM Hersh;TR Fleming;L Leichman
Journal / Conference
Anti-Cancer Drugs 3(3):211-217
Year
1992
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8755, SWOG-8760

Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement.

Authors
WF Kern;CM Spier;EH Hanneman;TP Miller;M Matzner;TM Grogan
Journal / Conference
Blood 79(9):2432-2437
Year
1992
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819